日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes

内皮细胞HIF-2α调控小鼠病理性血管生成和血管重建过程

Skuli, Nicolas; Majmundar, Amar J; Krock, Bryan L; Mesquita, Rickson C; Mathew, Lijoy K; Quinn, Zachary L; Runge, Anja; Liu, Liping; Kim, Meeri N; Liang, Jiaming; Schenkel, Steven; Yodh, Arjun G; Keith, Brian; Simon, M Celeste

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future

如何评估疫苗的全部经济价值?从过去到现在,汲取经验教训,展望未来

Standaert, Baudouin; Sauboin, Christophe; DeAntonio, Rodrigo; Marijam, Alen; Gomez, Jorge; Varghese, Lijoy; Zhang, Sharon

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old

重组带状疱疹疫苗在德国60岁及以上人群中的成本效益分析

Van Oorschot, Desirée; Anastassopoulou, Anastassia; Poulsen Nautrup, Barbara; Varghese, Lijoy; von Krempelhuber, Alfred; Neine, Mohamed; Lorenc, Stéphane; Curran, Desmond

Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

非活性佐剂重组带状疱疹疫苗对加拿大成年人的公共卫生影响及成本效益分析

McGirr, Ashleigh; Van Oorschot, Desiree; Widenmaier, Robyn; Stokes, Michael; Ganz, Michael L; Jung, Hyosung; Varghese, Lijoy; Curran, Desmond

Glucocorticoid receptor-dependent induction of cripto-1 (one-eyed pinhead) inhibits zebrafish caudal fin regeneration

糖皮质激素受体依赖性诱导的cripto-1(独眼针头)抑制斑马鱼尾鳍再生

Garland, Michael A; Sengupta, Sumitra; Mathew, Lijoy K; Truong, Lisa; de Jong, Esther; Piersma, Aldert H; La Du, Jane; Tanguay, Robert L

MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers

MEK抑制剂能够克服多种实体瘤和血液肿瘤对BET抑制剂的耐药性。

Wyce, Anastasia; Matteo, Jeanne J; Foley, Shawn W; Felitsky, Daniel J; Rajapurkar, Satyajit R; Zhang, Xi-Ping; Musso, Melissa C; Korenchuk, Susan; Karpinich, Natalie O; Keenan, Kathryn M; Stern, Melissa; Mathew, Lijoy K; McHugh, Charles F; McCabe, Michael T; Tummino, Peter J; Kruger, Ryan G; Carpenter, Christopher; Barbash, Olena

Comment on: 'Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada', Wilson et al., 22 June 2018

评论:Wilson等人于2018年6月22日发表的题为“加拿大婴儿肺炎球菌结合疫苗从13价疫苗转向10价疫苗的潜在临床和经济影响”的文章

McGirr, Ashleigh; Iqbal, Shehzad M; Olbrecht, Jan; Varghese, Lijoy

Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea

韩国幼儿和老年人接种四价流感疫苗与接种三价流感疫苗的成本效益比较

Kim, Yun-Kyung; Song, Joon Young; Jang, Hyeongap; Kim, Tae Hyun; Koo, Heejo; Varghese, Lijoy; Han, Euna

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis

日本50岁及以上人群接种带状疱疹疫苗的潜在公共卫生影响:马尔可夫模型分析结果

Watanabe, Daisuke; Mizukami, Akiko; Holl, Katsiaryna; Curran, Desmond; Van Oorschot, Desirée; Varghese, Lijoy; Shiragami, Makoto

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand

新西兰全民大规模接种中,10价肺炎球菌非典型流感嗜血杆菌蛋白D结合疫苗(PHiD-CV)与13价肺炎球菌结合疫苗(PCV13)的成本效益分析

Varghese, Lijoy; Talbot, Louise; Govender, Andrea; Zhang, Xu-Hao; Mungall, Bruce A